SST and neoplasm: Additionally, we evaluated the effect of the bifunctional chelator (BFC) on the pharmacokinetic properties and tumor uptake by labeling the SST agonist Tyr3-octreotate (TATE) with copper-61 using two different conjugates: DOTA-TATE and NOTA-TATE.